Literature DB >> 15876283

Gender difference in HIV-1 RNA viral loads.

C A Donnelly1, L M Bartley, A C Ghani, A M Le Fevre, G P Kwong, B J Cowling, A I van Sighem, F de Wolf, R A Rode, R M Anderson.   

Abstract

OBJECTIVES: To test and characterize the dependence of viral load on gender in different countries and racial groups as a function of CD4 T-cell count.
METHODS: Plasma viral load data were analysed for > 30,000 HIV-infected patients attending clinics in the USA [HIV Insight (Cerner Corporation, Vienna, VA, USA) and Plum Data Mining LLC (East Meadow, NY, USA) databases] and the Netherlands (Athena database; HIV Monitoring Foundation, Amsterdam, Netherlands). Log-normal regression models were used to test for an effect of gender on viral load while adjusting for covariates and allowing the effect to depend on CD4 T-cell count. Sensitivity analyses were performed to test the robustness of conclusions to assumptions regarding viral loads below the lower limit of quantification (LLOQ).
RESULTS: After adjusting for covariates, women had (nonsignificantly) lower viral loads than men (HIV Insight: -0.053 log(10) HIV-1 RNA copies/mL, P = 0.202; Athena: -0.005 log(10) copies/mL, P = 0.667; Plum: -0.072 log(10) copies/mL, P = 0.273). However, further investigation revealed that the gender effect depended on CD4 T-cell count. Women had consistently higher viral loads than men when CD4 T-cell counts were at most 50 cells/microL, and consistently lower viral loads than men when CD4 T-cell counts were greater than 350 cells/microL. These effects were remarkably consistent when estimated independently for the racial groups with sufficient data available in the HIV Insight and Plum databases.
CONCLUSIONS: The consistent relationship between gender-related differences in viral load and CD4 T-cell count demonstrated here explains the diverse findings previously published.

Entities:  

Mesh:

Year:  2005        PMID: 15876283     DOI: 10.1111/j.1468-1293.2005.00285.x

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  20 in total

1.  Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania.

Authors:  Elmar Saathoff; Michael Pritsch; Christof Geldmacher; Oliver Hoffmann; Rebecca N Koehler; Leonard Maboko; Lucas Maganga; Steffen Geis; Francine E McCutchan; Gustavo H Kijak; Jerome H Kim; Miguel A Arroyo; Martina Gerhardt; Sodsai Tovanabutra; Merlin L Robb; Carolyn Williamson; Nelson L Michael; Michael Hoelscher
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

2.  High HIV-1 RNA Among Newly Diagnosed People in Botswana.

Authors:  Vladimir Novitsky; Melanie Prague; Sikhulile Moyo; Tendani Gaolathe; Mompati Mmalane; Etienne Kadima Yankinda; Unoda Chakalisa; Refeletswe Lebelonyane; Nealia Khan; Kathleen M Powis; Erik Widenfelt; Simani Gaseitsiwe; Scott L Dryden-Peterson; Molly Pretorius Holme; Victor De Gruttola; Pam Bachanas; Joseph Makhema; Shahin Lockman; M Essex
Journal:  AIDS Res Hum Retroviruses       Date:  2018-01-17       Impact factor: 2.205

3.  Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.

Authors:  Susan A Fiscus; Susan Cu-Uvin; Abel Tilahun Eshete; Michael D Hughes; Yajing Bao; Mina Hosseinipour; Beatriz Grinsztejn; Sharlaa Badal-Faesen; Joan Dragavon; Robert W Coombs; Ken Braun; Laura Moran; James Hakim; Timothy Flanigan; N Kumarasamy; Thomas B Campbell
Journal:  Clin Infect Dis       Date:  2013-03-26       Impact factor: 9.079

4.  Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a(bright) activated T cells.

Authors:  Li Yin; Carina A Rodriguez; Wei Hou; Olivia Potter; Margaret J Caplan; Maureen M Goodenow; John W Sleasman
Journal:  J Allergy Clin Immunol       Date:  2008-06-09       Impact factor: 10.793

5.  Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach.

Authors:  George Shirreff; Lorenzo Pellis; Oliver Laeyendecker; Christophe Fraser
Journal:  PLoS Comput Biol       Date:  2011-10-13       Impact factor: 4.475

6.  Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters.

Authors:  M Eugenia Socías; Omar Sued; Natalia Laufer; María E Lázaro; Horacio Mingrone; Daniel Pryluka; Carlos Remondegui; María I Figueroa; Carina Cesar; Ana Gun; Gabriela Turk; María B Bouzas; Ravi Kavasery; Alejandro Krolewiecki; Héctor Pérez; Horacio Salomón; Pedro Cahn
Journal:  J Int AIDS Soc       Date:  2011-08-10       Impact factor: 5.396

7.  Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands.

Authors:  Luuk Gras; Suzanne Jurriaans; Margreet Bakker; Ard van Sighem; Daniela Bezemer; Christophe Fraser; Joep Lange; Jan M Prins; Ben Berkhout; Frank de Wolf
Journal:  PLoS One       Date:  2009-10-07       Impact factor: 3.240

8.  Modeling AIDS survival after initiation of antiretroviral treatment by Weibull models with changepoints.

Authors:  Constantin T Yiannoutsos
Journal:  J Int AIDS Soc       Date:  2009-06-26       Impact factor: 5.396

9.  Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load.

Authors:  Rebecca F Baggaley; Jamie T Griffin; Ruth Chapman; T Déirdre Hollingsworth; Nicolas Nagot; Sinead Delany; Philippe Mayaud; Frank de Wolf; Christophe Fraser; Azra C Ghani; Helen A Weiss
Journal:  AIDS       Date:  2009-05-15       Impact factor: 4.177

10.  Predictors of disease progression in HIV infection: a review.

Authors:  Simone E Langford; Jintanat Ananworanich; David A Cooper
Journal:  AIDS Res Ther       Date:  2007-05-14       Impact factor: 2.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.